-
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
05 Apr 2025 08:44 GMT
… Drug Administration (FDA) awarded xanomeline/trospium approval for the treatment … Trial Design
The pivotal EMERGENT-1, EMERGENT-2, and EMERGENT-3 trials … , and Takeda Pharmaceuticals. The authors report … 13, 2025.
32. RISPERDAL. (risperidone) tablets, …
-
Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment
01 Apr 2025 15:14 GMT
… of medical care. Maintenance treatment also … Acadia Pharmaceuticals)
Quetiapine (Seroquel; CHEPLAPHARM)
Risperidone (Risperdal; Janssen Pharmaceuticals, Inc … Unlike the oral pill burden, LAIs … ;fda-approves-drug-new-mechanism-action-treatment-schizophrenia …
-
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia
14 Mar 2025 15:54 GMT
… to antipsychotic medication treatment.2,20
… and Drug Administration (FDA) for the treatment of … Novo Nordisk, Otsuka, PPD Biotech, Recordati, Relmada, Reviva, … Janssen Pharmaceuticals. 2024.
24. Risperdal [package insert]. Janssen Pharmaceuticals. 2022 …
-
FDA Approved Drug Products Approval List January 2025
11 Mar 2025 11:43 GMT
Approval Date Drug Name Submission Active Ingredients Company … 01/22/2025 RISPERDAL CONSTANDA #021346 SUPPL-65 RISPERIDONE … #761036 SUPPL-51 DARATUMUMAB JANSSEN BIOTECH Approval 01/24…
-
When medications make teeth grind
07 Mar 2025 14:00 GMT
… for ADHD medications and antidepressants have skyrocketed. … Risperdal)
Haloperidol (Haldol)
Chlorpromazine
Trifluoperazine
Perphenazine
Parkinson’s medications
Medications … for conventional treatments such as nightguards … the Digital Drug Handbook come in …
-
Antidepressants Market to Reach USD 37.44 Billion by 2032, Growing at 7.66% CAGR
28 Feb 2025 13:03 GMT
… Takeda: Vyvanse (lisdexamfetamine)
• Janssen Pharmaceuticals: Risperdal (risperidone)
• Novartis: Trileptal ( … patients with treatment-resistant or … access to medication, has mainly … pharmaceutical companies and the launch of new antidepressant drugs …
-
DeFloria launches Phase II ASD irritability cannabis therapy trial
25 Feb 2025 05:14 GMT
… from the US Food and Drug Administration (FDA) for the orally delivered … and multiple-ascending dose (MAD) trial (NCT06019065) found AJA001 to be … Innovative Medicine’s Risperdal (risperidone) and Otsuka Pharmaceutical’s Abilify (aripiprazole). All drugs are …
-
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
10 Feb 2025 22:59 GMT
… treatment can optimize systemic drug exposure, reduce drug … medical policies with different coverage determinations (eg, RCTs and systematic reviews for antidepressants … .com
16. Risperdal. Prescribing information. Janssen; … tests. Nat Biotechnol. 2017;35(7 …
-
Post-Traumatic Stress Disorder Treatment Projected to Reach USD 22.85 Billion by 2032, Growing at a CAGR of 4.81%
24 Jan 2025 10:46 GMT
… Risperdal, Invega)
• Bristol-Myers Squibb Company (Abilify, Serzone)
• Otsuka Pharmaceutical … inhibitor SNRI medication, venlafaxine.
… Treatment Market Segmentation
By drug class
• Antidepressants
• Anti-anxiety
• Antipsychotics
• Other Drug …
-
Duopa interactions: Alcohol, medications, and other factors
08 Jan 2025 15:28 GMT
… with Duopa:
risperidone (Risperdal)
haloperidol (Haldol)
metoclopramide … CNS depression throughout treatment.
The following information … been enough clinical trials to determine … doctor or another healthcare professional before taking any medication. The drug …
About
© 1995-2025